Recently, @michyong.bsky.social presented at the 9th Annual #ICBMT2025 in Busan, Korea on CMV Infection in Allogeneic HSCT: Risk Stratification and Prevention, focused on advances in prophylaxis for CMV management after allogeneic hematopoietic stem cell transplantation- Congratulations!

he NCIC September newsletter is out! 📢 Read all about our research updates, recent publications and upcoming events: cancerandinfections.org/newsletter

Australia’s first multi-site study of infections in cancer & transplant patients, PROSPER, is now published in BMJ Open! It will guide future infection prevention & control for this vulnerable group. Read the full article here: bmjopen.bmj.com/content/15/7...

Pleased to publish the INTERACT study - describing current infection prevention & surveillance practice in the care of Australasian cancer/transplant patients & areas for future research (& thankful to all who participated) 🌟 @ncicancer.bsky.social #TxID #IDSky www.ajicjournal.org/article/S019...

You're invited to the NCIC Showcase! Learn about our work in infection & cancer care through rapid 2-min talks from clinicians, scientists & more. 📅 7 Aug | 🕧 12:30–2PM | 🏢 PMCC & Teams 🍽️ Lunch/tea included Register here: cancerandinfections.org/ncic-showcase

Join us for the Asia Fungal Working Group and ASID's ANZMIG Fungal Frontier Asia Pacific webinar on Emerging Dermatophyte Infections: Arrival of Antifungal Drug Resistance. 📅 Date: 3rd of September ⌚ Time: 19.30 AEST 📍 Location: Online 👉 Register here: asidevents.eventsair.com/anzmig-2025-...

📰 July Newsletter is Out Now! Catch up on the latest updates, research highlights, and upcoming events. 📖 Read it here: cancerandinfections.org/newsletter

2 WEEKS AWAY Join us for this hybrid event on Friday July 25th in Melbourne where we will hear updates in candida and other yeast clinical and laboratory diagnosis and management, as well the "ins and outs" of the Australasia Candidaemia Study III. Register: cancerandinfections.org/acsiii-regis...

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial url: academic.oup.com/jid/article-...

Sign up today on our website: cancerandinfections.org

We were proud to be well represented at the inaugural The Transplantation Society of Australia and New Zealand Infectious Disease Day on 20 June 2025 — a fantastic event co-badged with ASID Immunocompromised Host Special Interest Group.

New Publication! Professor Monica Slavin - “Very pleased to be part of this important study of olorofim, a novel antifungal drug for difficult-to-treat fungal infections. It was active against infections resistant to or failing existing treatments and offers a much-needed option for our patients.”

Pleased to present our subgroup analysis @TSANZ. Would IPC specific to the SOT cohort be valuable? Which HAIs/OIs should we monitor, and how do we build a national framework for success? @ncicancer.bsky.social #TxID #IDSky

Today, Belinda Lambros, presented on the Nursing Considerations from the Australasian Consensus Guidelines for Neutropenic Fever 2024 update at the 2025 Cancer Nurses Society Of Australia (CNSA) and International Society of Nurses in Cancer Care ISNCC congress.

Happy Friday! The June edition of the NCIC Newsletter is now live. To read, please visit: cancerandinfections.org/newsletter

We're Hiring! 2026 Peter MacCallum Cancer Centre ID Registrar This is a fully accredited advanced trainee position for an ID physician looking for further training in the Immunocompromised Host, based at the Peter MacCallum Cancer Centre. Learn more: careers.petermac.org/job/MELBOURN...

This week, we said farewell to Enric, our visiting research fellow from Spain, who spent the past three months with us. We wish him all the best in his future endeavors! Learn more about our visiting fellow program: cancerandinfections.org/visiting-fel...

Join us next Wednesday for the Asia Fungal Working Group and the Australia & New Zealand Mycology Interest Group (ANZMIG) webinar. Dr Abby Douglas is an invited expert panelist! Wednesday, May 28 7:00 PM – 8:30 PM AEST Fungus in a Joint – Osteoarticular Infections Register here: bit.ly/FFAP2025

Happy Infectious Diseases Pharmacists Day to my colleagues, mentors, and clinician-researcher heroes #IDPharmacistsDay #SIDPAdvocacy @adphaau.bsky.social @sidpharm.bsky.social @ncicancer.bsky.social

We are proud to share that the amazing Antibiotic Allergy Nursing Team has been nominated for the @petermaccc.bsky.social Annual Nursing Awards in celebration of International Nurses Day. Well done team!

Day 2 of the @petermaccc.bsky.social Research Symposium opened with A/Prof @michyong.bsky.social plenary on "Transforming the care of Infectious Diseases in Cancer Patients." Discussing groundbreaking research and future directions in fungal, viral, bacterial, and vaccine clinical trials.

Happy Friday! The latest NCIC Newsletter is out now. Catch up on key updates and news. Check it out here: cancerandinfections.org/newsletter

NCIC Fellow A/Prof Michelle Yong giving us all a great lesson in the complexities of viral infection post transplant #escmidglobal

Another head scratcher case for Monica and Dimitrios #escmidglobal

Prof Slavin discussing a very unusual case #escmidglobal Clinical grand rounds

NCIC fellow Dr Abby Douglas and next gen sequencing have found many ICH pts have previously undetected viruses (incl pegiviruses) that are associated with worse outcomes. Markers of overall immunosuppression or causative??#escmidglobal

NCIC Dr Zoe Neoh presenting results of the NAM study- 21 centres, 420 cases, emergence of non aspergillosis moulds #escmidglobal

NCIC visiting fellow alum Dr Julien Coussement presenting results of his ANZ crypto study- higher risk of IRIS. #escmidglobal

Full house for Prof Karin Thursky’s keynote tour de force - new frontiers in AMS.

A/Prof Ben Teh presenting his and NCIC PhD candidate Dr Tori Halls work on respiratory viruses in people with haem malignancy at #escmidglobal flash poster session. RSV in particular associated with more severe disease

Prof Slavin -New approaches needed for mycology clinical trials to overcome difficulties associated with rare cases#escmidglobal

Prof Monica Slavin at the meet the experts on Mycology clinical trials- have you participated?#escmidglobal

NCIC PhD Gemma Reynolds presenting a fantastic ICH &infection case#escmidglobal

NCIC Fellow @michyong.bsky.social on why we need antiviral stewardship programs and how to implement them

We are excited for #ESCMIDGLOBAL - the premier event for Infectious Diseases and Microbiology hosted by @escmid.bsky.social in Vienna, Austria! 🌍 If you're planning to attend, we’d love to connect with you. Below are the details of our presentations, including titles, times, and locations.

Day 2 of the Australasian Society for Infectious Diseases (ASID) ASM in Canberra, our incredible NCIC team proudly showcased their poster presentations. It was a fantastic opportunity to showcase their hard work and dedication to advancing the ICH space on a national stage!

Great 1st day at Australasian Society for Infectious Diseases meeting! @michyong.bsky.social led an insightful CMV symposium @benwteh.bsky.social chaired the "What's New in.." session as part of ICHSIG @priyagargiddoc.bsky.social comprehensive talk on key developments and gaps in the ICHS space

Join A/Professor @michyong.bsky.social this Thursday 3rd of April at 10 am ET, for the @ichs-global.bsky.social Early Career virtual networking session to connect, collaborate, and shape the future of Early Career programs! To learn more and sign up: ichs.wildapricot.org/page-1863364

Congratulations to Dr. Olivia Smibert on PhD pre-completion talk! 🎓 She presented her outstanding research on "The Gut Microbiota in Specialty Patient Populations." Congratulations to her supervisors Prof Monica Slavin, @trubianojason.bsky.social, @kwongjc.bsky.social and @kate-fisher.bsky.social

Farewell, Dr. Jia HuiLoh, our Visiting 12 month stay Fellow from Malaysia. "The opportunity to participate in clinical trials and research has not only deepened my knowledge but also broadened my perspective in the research field." Visiting fellow program: cancerandinfections.org/visiting-fel...

Happy Friday! Check out the NCIC March Newsletter for our latest updates. Find the link here: cancerandinfections.org/newsletter/2...

As part of our #IWD reflections, we surveyed the NCIC team to understand what's slowing progress towards gender equity in #clinical #research. The top response? Societal expectations around household work and childcare limiting women’s opportunities. Share with us what you think- do you agree?

#ASA2025 in Melbourne! 🌟 @michyong.bsky.social discussed alternative antiviral treatments for COVID-19. Last night, Prof Karin Thursky delivered the prestigious Howard Florey Oration, and today, A/Prof Gabrielle Haesuler led the 'Year in Review' session. Inspiring moments from our leaders!

What a way to wrap up Day 1 of #ASA2025 with our Director Prof Kas Thursky delivering the prestigious Howard Florey Oration. We’re so proud to be a part of her visionary work pioneering #AMS in Australia and internationally and driving the field forward. @ausantibiotics.bsky.social

Join us at the 15th Febrile Neutropenia Symposium, taking place online on March 15–16, 2025! NCIC Researcher, @benwteh.bsky.social, will present on 'Standardised Reporting of Infection Events in Immunocompromised Patients.' To learn more and sign up: cdn.wildapricot.com/24830/resour...

Happy International Women in Science Day! With over 85% of our cohort being women, we are dedicated to promoting, supporting, and strengthening women in science! Discover the achievements of these women here: cancerandinfections.org/phd-pathways @michyong.bsky.social @abbydouglas.bsky.social

On #WorldCancerDay, we honor those affected by cancer and highlight the EINSTEIN project, which aims to revolutionize infection detection in immunocompromised cancer patients. EINSTEIN uses AI and medical records to detect infections early. Learn more: cancerandinfections.org/infection-su...

👋 We are searching for a clinical research fellow to join our team! 👋 Submit your application today! Don’t miss out—applications close Wednesday, February 12th. Share this incredible opportunity with others!

Very proud of this hard work & team effort from all involved! Limited benefit of adjuvanted flu 💉 & 2 vs 1 dose in pts w/ MM, CLL or NHL. @ncicancer.bsky.social @petermaccc.bsky.social @benwteh.bsky.social @trubianojason.bsky.social @michyong.bsky.social @nejm.org www.nejm.org/doi/full/10....

Only a couple of weeks left – don’t miss this opportunity! Join leading experts for the International Immunocompromised Host Society “Controversies in the Vaccination of Immunocompromised Patients” webinar on February 6, 2025. Learn more about this event here: buff.ly/4a8g77q